Literature DB >> 23602049

The role of inflammatory chemokines in lymphoid neoorganogenesis in breast cancer.

S K Gantsev1, K Umezawa, D V Islamgulov, E K Khusnutdinova, R S Ishmuratova, V Y Frolova, S R Kzyrgalin.   

Abstract

The expression profiling analysis of inflammatory chemokines and their receptors in newly formed lymph nodes in breast cancer was carried out. The analysis revealed the increase in expression of the genes CCL16, XCR1, CYFIP2, TNFSF14 and the reduction in expression of chemokine ligands CXCL5 and CXCL12 in tertiary lymphoid organs. The obtained results allow us to suggest that the process of induction of lymph nodes neogenesis is identical (in its key mechanisms) to the process of lymphoid tissue neogenesis in autoimmune diseases and in some infections, but may have different triggers.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602049     DOI: 10.1016/j.biopha.2013.03.017

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  Exome sequencing in a breast cancer family without BRCA mutation.

Authors:  Jae Myoung Noh; Jihun Kim; Dae Yeon Cho; Doo Ho Choi; Won Park; Seung Jae Huh
Journal:  Radiat Oncol J       Date:  2015-06-30

Review 2.  Tumor necrosis factor superfamily in innate immunity and inflammation.

Authors:  John Šedý; Vasileios Bekiaris; Carl F Ware
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-18       Impact factor: 10.005

3.  Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.

Authors:  P Elumalai; A Brindha Mercy; R Arunkamar; G Sharmila; F A Bhat; S Balakrishnan; P Raja Singh; J Arunakaran
Journal:  Cell Prolif       Date:  2014-12       Impact factor: 6.831

Review 4.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

Review 5.  Molecular mechanisms and clinical management of cancer bone metastasis.

Authors:  Manni Wang; Fan Xia; Yuquan Wei; Xiawei Wei
Journal:  Bone Res       Date:  2020-07-29       Impact factor: 13.567

6.  Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome.

Authors:  Piotr Laudanski; Monika Zbucka-Kretowska; Karol Charkiewicz; Slawomir Wolczynski; Daniela Wojcik; Radoslaw Charkiewicz
Journal:  Mediators Inflamm       Date:  2014-11-16       Impact factor: 4.711

Review 7.  Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?

Authors:  Emily Jayne Colbeck; Ann Ager; Awen Gallimore; Gareth Wyn Jones
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

8.  Driver pattern identification over the gene co-expression of drug response in ovarian cancer by integrating high throughput genomics data.

Authors:  Xinguo Lu; Jibo Lu; Bo Liao; Xing Li; Xin Qian; Keqin Li
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

9.  CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.

Authors:  Li Li; Li Xu; Jing Yan; Zuo-Jun Zhen; Yong Ji; Chao-Qun Liu; Wan Yee Lau; Limin Zheng; Jing Xu
Journal:  J Exp Clin Cancer Res       Date:  2015-10-26

10.  The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.

Authors:  Peixin Huang; Xiaojing Xu; Lingyan Wang; Bijun Zhu; Xiangdong Wang; Jingling Xia
Journal:  J Cell Mol Med       Date:  2013-11-25       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.